Intraperitoneal Paclitaxel for Patients With Primary Malignant Peritoneal Mesothelioma

Clinical trial NCT05449366 · COMPLETED

Trial details

NCT number: NCT05449366
Sponsor: Erasmus Medical Center
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Peritoneal Malignant Mesothelioma

Start date: 2022-02-01
Primary completion: 2025-06-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.